miRecule

Sanofi, miRecule Ink Muscular Dystrophy Research Deal Worth up to $430M
BioSpace
Tue, 10/4/22 - 11:43 pm
Sanofi
miRecule
myotonic muscular dystrophy
Sanofi licenses a preclinical genetic disease drug from an unknown biotech spun out of the NIH
Endpoints
Tue, 10/4/22 - 10:47 am
Sanofi
antibody-RNA conjugate
miRecule
FSHD